Difficulty: Medium
Average Score: 92%
Practice
Dietary supplementation with DHEA is best documented to have therapeutic value in the treatment of
Correct answer
D
Rationale
In this case, the correct answer is D) Postmenopausal osteoporosis. Dehydroepiandrosterone (DHEA) is a precursor to hormones like estrogen and testosterone, and its supplementation has been studied for its potential benefits in postmenopausal women, particularly in improving bone mineral density and reducing the risk of osteoporosis.
Option A) Acne is not a condition typically treated with DHEA supplementation. Acne is more commonly addressed through topical treatments or medications targeting hormonal imbalances.
Option B) Diabetes insipidus is a condition characterized by excessive thirst and urination due to inadequate vasopressin production or action. DHEA supplementation is not a standard treatment for this disorder.
Option C) Hirsutism in female patients refers to excessive hair growth in areas where hair is normally minimal or absent. While hormonal imbalances can contribute to hirsutism, DHEA supplementation is not the primary treatment for this condition.
Educationally, understanding the therapeutic uses of various drugs is crucial for healthcare professionals in providing effective and evidence-based care to patients. Knowing the specific conditions that a drug is indicated for helps in making informed decisions regarding treatment plans, ensuring optimal outcomes for patients. In the case of DHEA supplementation, recognizing its role in managing postmenopausal osteoporosis can potentially benefit women at risk for this condition.
Option A) Acne is not a condition typically treated with DHEA supplementation. Acne is more commonly addressed through topical treatments or medications targeting hormonal imbalances.
Option B) Diabetes insipidus is a condition characterized by excessive thirst and urination due to inadequate vasopressin production or action. DHEA supplementation is not a standard treatment for this disorder.
Option C) Hirsutism in female patients refers to excessive hair growth in areas where hair is normally minimal or absent. While hormonal imbalances can contribute to hirsutism, DHEA supplementation is not the primary treatment for this condition.
Educationally, understanding the therapeutic uses of various drugs is crucial for healthcare professionals in providing effective and evidence-based care to patients. Knowing the specific conditions that a drug is indicated for helps in making informed decisions regarding treatment plans, ensuring optimal outcomes for patients. In the case of DHEA supplementation, recognizing its role in managing postmenopausal osteoporosis can potentially benefit women at risk for this condition.